DK0413378T3 - Escherichia coli vaccine - Google Patents

Escherichia coli vaccine

Info

Publication number
DK0413378T3
DK0413378T3 DK90201990.0T DK90201990T DK0413378T3 DK 0413378 T3 DK0413378 T3 DK 0413378T3 DK 90201990 T DK90201990 T DK 90201990T DK 0413378 T3 DK0413378 T3 DK 0413378T3
Authority
DK
Denmark
Prior art keywords
escherichia coli
coli vaccine
vaccine
escherichia
coli
Prior art date
Application number
DK90201990.0T
Other languages
Danish (da)
English (en)
Inventor
Den Bosch Johannes Francis Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0413378T3 publication Critical patent/DK0413378T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK90201990.0T 1989-08-18 1990-07-23 Escherichia coli vaccine DK0413378T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89202110 1989-08-18

Publications (1)

Publication Number Publication Date
DK0413378T3 true DK0413378T3 (da) 1995-05-15

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90201990.0T DK0413378T3 (da) 1989-08-18 1990-07-23 Escherichia coli vaccine

Country Status (16)

Country Link
US (1) US5750115A (cs)
EP (1) EP0413378B1 (cs)
JP (1) JP3031561B2 (cs)
KR (1) KR0177510B1 (cs)
CN (1) CN1062605C (cs)
AU (1) AU635062B2 (cs)
CA (1) CA2022420C (cs)
DE (1) DE69016129T2 (cs)
DK (1) DK0413378T3 (cs)
ES (1) ES2070266T3 (cs)
GR (1) GR3015782T3 (cs)
HU (2) HU210965B (cs)
IL (1) IL95175A (cs)
NZ (1) NZ234933A (cs)
TW (1) TW204353B (cs)
ZA (1) ZA906100B (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042718T3 (es) * 1987-10-26 1993-12-16 Akzo Nv Procedimiento para la preparacion de una vacuna para proteger aves de corral contra septicemia producida por e. coli.
US6749831B1 (en) 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
JP2001527562A (ja) * 1997-05-16 2001-12-25 メディカル ディフェンス テクノロジーズ エルエルシー リポ多糖コアに対するワクチン
BR9910438A (pt) * 1998-05-15 2001-01-02 Mkb Invest Ltd Partnership Composições e processos para imunização de aves domésticas
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
EP1934349A4 (en) * 2005-08-30 2009-05-27 Commw Scient Ind Res Org BACTERIAL INTRODUCTION OF BIOLOGICALLY ACTIVE POLYPEPTIDES
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
NZ599890A (en) 2009-10-12 2014-03-28 Univ Pittsburgh Oxygen depletion devices and methods for removing oxygen from red blood cells
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
NZ599891A (en) 2009-10-12 2014-06-27 New Health Sciences Inc Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
ES2959120T3 (es) 2010-08-25 2024-02-20 Hemanext Inc Método para potenciar la calidad y la supervivencia de glóbulos rojos durante el almacenamiento
JP5859558B2 (ja) 2010-11-05 2016-02-10 ニュー・ヘルス・サイエンシーズ・インコーポレイテッドＮｅｗ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅｓ， Ｉｎｃ． 赤血球の照射及び嫌気性保存
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
WO2013009843A1 (en) * 2011-07-11 2013-01-17 Camas Incorporated Compositions against bacterial toxins
WO2013023156A1 (en) 2011-08-10 2013-02-14 New Health Sciences, Inc. Integrated leukocyte, oxygen and/or co2 depletion, and plasma separation filter device
WO2014134503A1 (en) 2013-02-28 2014-09-04 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
CA3211996A1 (en) 2015-03-10 2016-09-15 Hemanext Inc. Oxygen reduction disposable kits, devices and methods of use thereof
CN107847395B (zh) 2015-04-23 2021-10-15 新健康科学股份有限公司 厌氧血液储存容器
CN114748503B (zh) 2015-05-18 2025-09-30 希玛奈克斯特股份有限公司 储存全血的方法及其组合物
KR102701687B1 (ko) 2016-05-27 2024-08-30 헤마넥스트 인코포레이티드 혐기성 혈액 저장 및 병원체 불활성화 방법
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4702911A (en) 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
ES2060580T3 (es) * 1986-03-11 1994-12-01 Shionogi & Co Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.

Also Published As

Publication number Publication date
CA2022420C (en) 2000-03-28
TW204353B (cs) 1993-04-21
HU905053D0 (en) 1991-01-28
CA2022420A1 (en) 1991-02-19
KR910004209A (ko) 1991-03-28
HUT59612A (en) 1992-06-29
ES2070266T3 (es) 1995-06-01
US5750115A (en) 1998-05-12
CN1049523A (zh) 1991-02-27
KR0177510B1 (ko) 1999-03-20
AU635062B2 (en) 1993-03-11
DE69016129T2 (de) 1995-05-24
NZ234933A (en) 1992-06-25
IL95175A0 (en) 1991-06-10
JPH03184996A (ja) 1991-08-12
DE69016129D1 (de) 1995-03-02
JP3031561B2 (ja) 2000-04-10
IL95175A (en) 1994-05-30
HU211827A9 (en) 1995-12-28
GR3015782T3 (en) 1995-07-31
EP0413378B1 (en) 1995-01-18
ZA906100B (en) 1991-05-29
CN1062605C (zh) 2001-02-28
AU6109990A (en) 1991-02-21
EP0413378A1 (en) 1991-02-20
HU210965B (en) 1995-09-28

Similar Documents

Publication Publication Date Title
DK0413378T3 (da) Escherichia coli vaccine
DK272889A (da) Vaccine
KR900011476A (ko) 백신 제제
FI906367A0 (fi) Terapeutiska nukleosider.
FI913899A0 (fi) Terapeutiska aerosolblandningar.
FI902502A0 (fi) Ampull.
FI935878L (fi) Porfycenfoereningar foer fotodynamisk terapi
DE69027112D1 (de) Impfstoffzusammensetzung
FI902555A7 (fi) Diaryylistyryylikinoliinidihappoja
DK189788D0 (da) Vaccine
FI904854A0 (fi) Terapeutiska nukleosider.
KR890700356A (ko) 신규의 백신
FI941399A7 (fi) Sparfloksasiiniliuos, sen valmistus ja sitä sisältävä suola
FI891832L (fi) Specialmutant av escherichia coli.
FI925032L (fi) Vaccinsammansaettningar
FI925333A0 (fi) Foerbaettrad produktion av poly-beta-hydroxibutyrat i transformerad escherichia coli
FI881411L (fi) Reglerbar kopplingsstav.
ATE134386T1 (de) Vakzin-zusammensetzung
FI894072A7 (fi) Rokotteena käytettävät polypeptidit
DE3853887D1 (de) Regelbares stangenendstück.
AT387650B (de) Waermepumpe
BR9007246A (pt) Preparacao de vacinas
DK149591D0 (da) Proteinpraeparat
FR2650634B1 (fr) Micropompe perfectionnee
LT2028B (lt) Bakteriju escherichia coli kamienas-restriktazes eco 130 1 producentas